BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25128973)

  • 1. Distinct phenotypes of cardiac allograft vasculopathy after heart transplantation: a histopathological study.
    Huibers MM; Vink A; Kaldeway J; Huisman A; Timmermans K; Leenders M; Schipper ME; Lahpor JR; Kirkels HJ; Klöpping C; de Jonge N; de Weger RA
    Atherosclerosis; 2014 Oct; 236(2):353-9. PubMed ID: 25128973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts.
    Lu WH; Palatnik K; Fishbein GA; Lai C; Levi DS; Perens G; Alejos J; Kobashigawa J; Fishbein MC
    J Heart Lung Transplant; 2011 Sep; 30(9):1044-50. PubMed ID: 21640617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and Fibrotic Mechanisms in Cardiac Allograft Vasculopathy.
    Jansen MA; Otten HG; de Weger RA; Huibers MM
    Transplantation; 2015 Dec; 99(12):2467-75. PubMed ID: 26285017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
    Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F
    J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin.
    Atkinson C; Horsley J; Rhind-Tutt S; Charman S; Phillpotts CJ; Wallwork J; Goddard MJ
    J Heart Lung Transplant; 2004 Apr; 23(4):427-35. PubMed ID: 15063402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intimal fibrosis in human cardiac allograft vasculopathy.
    Huibers M; De Jonge N; Van Kuik J; Koning ES; Van Wichen D; Dullens H; Schipper M; De Weger R
    Transpl Immunol; 2011 Sep; 25(2-3):124-32. PubMed ID: 21782945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of donor benign intimal thickening on cardiac allograft vasculopathy.
    Devitt JJ; Rice A; McLean D; Murray SK; Hirsch GM; Lee TD
    J Heart Lung Transplant; 2013 Apr; 32(4):454-60. PubMed ID: 23498165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ONO-4817, a novel matrix metalloproteinase inhibitor, attenuates allograft vasculopathy in a rat cardiac transplant.
    Hariya A; Takazawa K; Yamamoto T; Amano A
    J Heart Lung Transplant; 2004 Oct; 23(10):1163-9. PubMed ID: 15477110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness.
    Imamura T; Kinugawa K; Murasawa T; Kagami Y; Endo M; Muraoka H; Fujino T; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Komuro I; Ono M
    Int Heart J; 2014; 55(2):178-80. PubMed ID: 24632967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study).
    Khandhar SJ; Yamamoto H; Teuteberg JJ; Shullo MA; Bezerra HG; Costa MA; Selzer F; Lee JS; Marroquin OC; McNamara DM; Mulukutla SR; Toma C
    J Heart Lung Transplant; 2013 Jun; 32(6):596-602. PubMed ID: 23499356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.
    Ardehali A; Laks H; Drinkwater DC; Ziv E; Drake TA
    Circulation; 1995 Aug; 92(3):450-6. PubMed ID: 7543379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathological assessments of allografts after heart transplantation using a dog model--allograft vasculopathy].
    Hachida M; Nonoyama M; Hoshi H; Bonkohara Y; Sato M; Saito S; Uwabe K; Kitamura M; Endo M; Koyanagi H
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Aug; 41(8):1291-7. PubMed ID: 8360528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of allograft vasculopathy by intravascular ultrasound one month and one year after heart transplantation: A single center study.
    Bedanova H; Orban M; Tretina M; Fila P; Horvath V; Krejci J; Nemec P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):130-5. PubMed ID: 26220510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
    Soleimani B; Fu F; Lake P; Shi VC
    J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The composition of ectopic lymphoid structures suggests involvement of a local immune response in cardiac allograft vasculopathy.
    Huibers MM; Gareau AJ; Vink A; Kruit R; Feringa H; Beerthuijzen JM; Siera-de Koning E; Peeters T; de Jonge N; de Weger RA; Lee TD
    J Heart Lung Transplant; 2015 May; 34(5):734-45. PubMed ID: 25655346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of longitudinal myocardial deformation by 2-dimensional speckle-tracking echocardiography in heart transplant recipients: relation to coronary allograft vasculopathy.
    Clemmensen TS; Løgstrup BB; Eiskjær H; Poulsen SH
    J Heart Lung Transplant; 2015 Feb; 34(2):195-203. PubMed ID: 25108908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplant arterial vasculopathy: evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia.
    Aziz S; McDonald TO; Gohra H
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S123-36. PubMed ID: 8719474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease.
    Jonas M; Fang JC; Wang JC; Giri S; Elian D; Har-Zahav Y; Ly H; Seifert PA; Popma JJ; Rogers C
    J Am Coll Cardiol; 2006 Aug; 48(3):453-61. PubMed ID: 16875968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable proximal and distal severity of intimal thickening and size of epicardial coronary arteries in transplant arteriopathy of human cardiac allografts.
    Lin H; Wilson JE; Kendall TJ; Radio SJ; Cornhill FJ; Herderick E; Winters GL; Costanzo MR; Porter T; Thieszen SL
    J Heart Lung Transplant; 1994; 13(5):824-33. PubMed ID: 7803423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.